1. Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3
   Ye Wu et al, 2023, BMC Oral Health CrossRef
2. lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis
   Lin Zhu et al, 2021, Acta Biochimica et Biophysica Sinica CrossRef
3. Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway
   Yin Yang et al, 2023, Veterinary and Comparative Oncology CrossRef
4. Therapeutic potential of toosendanin: Novel applications of an old ascaris repellent as a drug candidate
   Minghao Hu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
5. Toosendanin and isotoosendanin suppress triple-negative breast cancer growth via inducing necrosis, apoptosis and autophagy
   Jingnan Zhang et al, 2022, Chemico-Biological Interactions CrossRef
6. The signaling pathways and targets of natural products from traditional Chinese medicine treating gastric cancer provide new candidate therapeutic strategies
   Yile Liao et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
7. MicroRNA-23a-3p influences the molecular mechanism of gastric cancer cells via CCL22/PI3K/Akt axis
   Zhipeng Jiang et al, 2021, Bioengineered CrossRef
8. CTPS cytoophidia formation affects cell cycle progression and promotes TSN‑induced apoptosis of MKN45 cells
   Xuepeng Fu et al, 2022, Molecular Medicine Reports CrossRef
9. Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: Recent advances and perspectives
   Qichao Hu et al, 2023, Phytotherapy Research CrossRef
10. Limonoids From the Genus Melia (Meliaceae): Phytochemistry, Synthesis, Bioactivities, Pharmacokinetics, and Toxicology
    Wenxiang Fan et al, 2022, Frontiers in Pharmacology CrossRef
11. Synergistic Anti‐Tumor Effect of Toosendanin and Paclitaxel on Triple‐Negative Breast Cancer via Regulating ADORA2A‐EMT Related Signaling
    Juan Zhang et al, 2023, Advanced Biology CrossRef
12. Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
    Shuang Zhang et al, 2022, Chinese Medicine CrossRef
13. Toosendanin reduces cisplatin resistance in ovarian cancer through modulating the miR-195/ERK/β-catenin pathway
    Ge Wang et al, 2023, Phytomedicine CrossRef
14. The therapeutic potential of natural products for treating pancreatic cancer
    Xia He et al, 2022, Frontiers in Pharmacology CrossRef